Vinge advises Bridgepoint Development Capital III and Bridgepoint Europe VI (”Bridgepoint”), founders as well as the other shareholders in connection with Cinven, an international private equity firm, acquiring a significant stake in Vitamin Well Group (“Vitamin Well”) and thereby becoming the new lead investor, while Bridgepoint, founders and the other shareholders will retain significant minority stakes following the transaction.

Vitamin Well, founded in 2008 and headquartered in Stockholm, is a fast-growing functional foods and beverage group offering premium products for health-conscious and active consumers. Today, the group has approximately 500 employees and a broad multi-brand product portfolio, including the core brands Vitamin Well (vitamin and mineral-enriched beverages), NOCCO (energy drinks) and Barebells (protein bars and shakes), which are sold internationally in more than 40 markets.

The transaction is subject to regulatory approvals.

Vinge’s team consisted mainly of Daniel Rosvall, Samra Tesser, Carl Fredrik Wachtmeister, Robin Fagerström, Sara Passandideh and Lovisa Jonassen (M&A), Albert Wållgren, Karl-Gustaw Tobola and Josef Groow (Banking and Finance), Ebba Svenburg and Jonna Skog (Employment), Arvid Axelryd (Intellectual Property), Karolina Cohrs (Real Estate), Christoffer Nordin, Martin Boström, Carla Zachariasson and Arthur Kinski (Commercial Agreements, IT and GDPR) David Olander, Lovisa Lewin and Hampus Peterson (EU and FDI Regulatory) Anders Leissner, Tyra von Mentzer and Gulestan Ali (Compliance), Jessica Öijer, Cecilia Loctander and Christoffer Widström (Transaction Support Coordinators).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025